Nevariss Pharmaceuticals Private Limited
About Nevariss Pharmaceuticals Private Limited
Data last updated:
Nevariss Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 09 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC378128. Its GSTIN is 07AAHCN4811C1ZT (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shahrukh Khan and Aleem Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.13 Kh. No. 77/9/1 G.F. Blovk – E Phase – 1 Vijay Vihar Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.17 Lakh, a decline of 60% compared to the previous year. For the same year it recorded a net loss of ₹1.51 Lakh (net margin -69.6%) and EBITDA of -₹1.33 Lakh (EBITDA margin -61.4%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years.
Company details
Contact details
Nevariss Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressH.No.13 Kh. No. 77/9/1 G.F. Blovk – E Phase – 1 Vijay Vihar Rohini, Delhi, India – 110085
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nevariss Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nevariss Pharmaceuticals Private Limited, buy the company report.
Financials of Nevariss Pharmaceuticals Private Limited
FY 2025 filings availableNevariss Pharmaceuticals Private Limited reported revenue of ₹2.17 Lakh (down 60% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over three years, including a 60% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -61.4% | ||||
| Net Profit Margin | -69.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nevariss Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nevariss Pharmaceuticals Private Limited
Nevariss Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shahrukh Khan | Director | 09 Mar 2021 | 5 Years 7 Months | Current |
| Aleem Khan | Director | 09 Mar 2021 | 5 Years 7 Months | Current |
| Nek Mohd | Director | 09 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Nevariss Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apricus Pharmaceuticals Private Limited | ₹2.19 Lakh (FY 2021) | Neemrana, Rajasthan, India | ||||
| Elmus Pharmaceuticals Private Limited | ₹2.19 Lakh (FY 2019) | 2090.0% | Hyderabad, Telangana, India | |||
| Nevariss Pharmaceuticals Private Limitedthis company | ₹2.17 Lakh (FY 2025) | -₹1.51 Lakh | -69.6% | -60.0% | Delhi, India | |
| Dermatrait Pharmaceuticals Private Limited | ₹2.17 Lakh (FY 2025) | -7.0% | Delhi, India |
To see the full peer comparison of Nevariss Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nevariss Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nevariss Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nevariss Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCN4811C1ZT | Delhi | Active | 01 May 2021 |
To see the full GST registrations and return filing status of Nevariss Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nevariss Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Aleem Khan was appointed as Director on 09 Mar 2021.
Frequently asked questions
Nevariss Pharmaceuticals is an active private limited company based in Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 09 March 2021 (5+ years old) and is registered under CIN U24299DL2021PTC378128.
Nevariss Pharmaceuticals has 3 current directors:
- Shahrukh Khan - Director
- Aleem Khan - Director
- Nek Mohd - Director
The latest financial statements of Nevariss Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Nevariss Pharmaceuticals is 07AAHCN4811C1ZT, registered in Delhi.
The CIN (Corporate Identification Number) of Nevariss Pharmaceuticals is U24299DL2021PTC378128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nevariss Pharmaceuticals was incorporated on 09 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nevariss Pharmaceuticals by revenue are Apricus Pharmaceuticals Private Limited, Elmus Pharmaceuticals Private Limited, Dermatrait Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Aleem Khan was appointed as Director on 09 Mar 2021. Nek Mohd was appointed as Director on 09 Mar 2021. Shahrukh Khan was appointed as Director on 09 Mar 2021.
The registered office of Nevariss Pharmaceuticals is at H.No.13 Kh. No. 7791 G.F. Blovk – E Phase – 1 Vijay Vihar Rohini, Delhi, India – 110085.
Nevariss Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Nevariss Pharmaceuticals can be reached at its registered office: H.No.13 Kh. No. 7791 G.F. Blovk – E Phase – 1 Vijay Vihar Rohini, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
